Ozenoxacin 1% Cream (Xepi) for Impetigo

Date: April 22, 2019
Issue #: 
1570Summary: 
The FDA has approved a 1% cream formulation
of ozenoxacin (Xepi– Cutanea), a nonfluorinated
quinolone antibiotic, for treatment of impetigo caused
by Staphylococcus aureus or Streptococcus pyogenes
in patients≥2 months old.

Source: The Medical Letter - March 20, 2019 Category: Drugs & Pharmacology Authors: admin Tags: Acne Altabax Antibacterials Bactroban Cephalexin Dicloxacillin Impetigo methicillin-resistant staphylococcus aureus mupirocin Ozanex ozenoxacin Retapamulin Xepi Source Type: research